Addison Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.58M | Buy |
29,746
+534
| +2% | +$61.6K | 0.64% | 43 |
|
|
2025
Q4 | $3.07M | Buy |
29,212
+6
| +0% | +$563 | 0.77% | 37 |
|
|
2025
Q3 | $2.44M | Sell |
29,206
-931
| -3% | -$76.7K | 0.72% | 36 |
|
|
2025
Q2 | $2.39M | Buy |
30,137
+10
| +0% | +$795 | 0.83% | 32 |
|
|
2025
Q1 | $2.7M | Sell |
30,127
-20
| -0.1% | -$1.87K | 1.06% | 26 |
|
|
2024
Q4 | $3M | Sell |
30,147
-1,264
| -4% | -$130K | 1.19% | 27 |
|
|
2024
Q3 | $3.57M | Buy |
31,411
+5
| +0% | +$594 | 1.44% | 21 |
|
|
2024
Q2 | $3.89M | Buy |
31,406
+965
| +3% | +$124K | 1.69% | 17 |
|
|
2024
Q1 | $4.02M | Buy |
30,441
+74
| +0.2% | +$9.12K | 2% | 14 |
|
|
2023
Q4 | $3.31M | Buy |
30,367
+24,571
| +424% | +$2.55M | 2.05% | 16 |
|
|
2023
Q3 | $596K | Buy |
5,796
+296
| +5% | +$31.9K | 0.46% | 51 |
|
|
2023
Q2 | $634K | Buy |
5,500
+184
| +3% | +$20.9K | 0.45% | 50 |
|
|
2023
Q1 | $566K | Sell |
5,316
-3,474
| -40% | -$375K | 0.43% | 49 |
|
|
2022
Q4 | $975K | Buy |
8,790
+112
| +1% | +$11.4K | 0.61% | 48 |
|
|
2022
Q3 | $747K | Buy |
8,678
+240
| +3% | +$21.4K | 0.46% | 58 |
|
|
2022
Q2 | $769K | Sell |
8,438
-324
| -4% | -$28.7K | 0.45% | 57 |
|
|
2022
Q1 | $719K | Sell |
8,762
-140
| -2% | -$11K | 0.34% | 69 |
|
|
2021
Q4 | $682K | Buy |
8,902
+2,838
| +47% | +$226K | 0.31% | 67 |
|
|
2021
Q3 | $455K | Sell |
6,064
-150
| -2% | -$11.4K | 0.21% | 73 |
|
|
2021
Q2 | $483K | Buy |
6,214
+837
| +16% | +$62.3K | 0.24% | 71 |
|
|
2021
Q1 | $396K | Buy |
5,377
+605
| +13% | +$44.6K | 0.22% | 74 |
|
|
2020
Q4 | $372K | Sell |
4,772
-38
| -0.8% | -$2.91K | 0.23% | 72 |
|
|
2020
Q3 | $381K | Sell |
4,810
-124
| -3% | -$9.71K | 0.27% | 67 |
|
|
2020
Q2 | $364K | Buy |
4,934
+191
| +4% | +$14.4K | 0.28% | 67 |
|
|
2020
Q1 | $348K | Buy |
4,743
+39
| +0.8% | +$3.06K | 0.25% | 74 |
|
|
2019
Q4 | $408K | Buy |
4,704
+307
| +7% | +$25.2K | 0.27% | 75 |
|
|
2019
Q3 | $353K | Sell |
4,397
-78
| -2% | -$6.25K | 0.25% | 83 |
|
|
2019
Q2 | $358K | Buy |
4,475
+466
| +12% | +$35.7K | 0.25% | 89 |
|
|
2019
Q1 | $318K | Hold |
4,009
| – | – | 0.24% | 88 |
|
|
2018
Q4 | $292K | Hold |
4,009
| – | – | 0.26% | 82 |
|
|
2018
Q3 | $271K | Buy |
4,009
+420
| +12% | +$26.8K | 0.2% | 97 |
|
|
2018
Q2 | $208K | Buy |
+3,589
| New | +$202K | 0.16% | 107 |
|
|
2017
Q4 | – | Sell |
-3,380
| Closed | -$206K | – | 115 |
|
|
2017
Q3 | $206K | Sell |
3,380
-209
| -6% | -$12.7K | 0.18% | 98 |
|
|
2017
Q2 | $220K | Hold |
3,589
| – | – | 0.18% | 96 |
|
|
2017
Q1 | $218K | Buy |
+3,589
| New | +$218K | 0.18% | 98 |
|
|
2015
Q3 | – | Sell |
-4,844
| Closed | -$263K | – | 94 |
|
|
2015
Q2 | $263K | Buy |
4,844
+1,158
| +31% | +$64.9K | 0.24% | 72 |
|
|
2015
Q1 | $202K | Buy |
+3,686
| New | +$209K | 0.16% | 88 |
|
Other funds holding MRK
VCM
VPM
Addison Capital's MRK Position: Q1 2026 in Review
Addison Capital increased its Merck (MRK) stake by 1.8% in Q1 2026, buying an estimated $61.6K and bringing the position to 29,746 shares worth $3.58M. The position accounts for 0.64% of the portfolio, ranked #43.
Addison Capital first reported a position in MRK in Q1 2015 and has held it in 37 quarters since. The position peaked at $4.02M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Addison Capital held 29,746 shares of Merck worth $3.58M as of Q1 2026.
- Addison Capital bought 534 Merck shares in Q1 2026, an estimated $61.6K.
- Merck made up 0.64% of Addison Capital's portfolio in Q1 2026, its #43 holding.
- Addison Capital first reported a position in Merck in Q1 2015 and has held it in 37 quarters since.
- Addison Capital's Merck position peaked at $4.02M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Addison Capital's 13F filing for Q1 2026, filed 29 Apr 2026.